1. Home
  2. APLS vs AIR Comparison

APLS vs AIR Comparison

Compare APLS & AIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLS
  • AIR
  • Stock Information
  • Founded
  • APLS 2009
  • AIR 1951
  • Country
  • APLS United States
  • AIR United States
  • Employees
  • APLS N/A
  • AIR N/A
  • Industry
  • APLS Biotechnology: Pharmaceutical Preparations
  • AIR Aerospace
  • Sector
  • APLS Health Care
  • AIR Industrials
  • Exchange
  • APLS Nasdaq
  • AIR Nasdaq
  • Market Cap
  • APLS 2.2B
  • AIR 2.4B
  • IPO Year
  • APLS 2017
  • AIR 1988
  • Fundamental
  • Price
  • APLS $17.69
  • AIR $67.59
  • Analyst Decision
  • APLS Buy
  • AIR Strong Buy
  • Analyst Count
  • APLS 19
  • AIR 6
  • Target Price
  • APLS $37.67
  • AIR $80.67
  • AVG Volume (30 Days)
  • APLS 2.1M
  • AIR 231.8K
  • Earning Date
  • APLS 07-31-2025
  • AIR 07-17-2025
  • Dividend Yield
  • APLS N/A
  • AIR N/A
  • EPS Growth
  • APLS N/A
  • AIR N/A
  • EPS
  • APLS N/A
  • AIR N/A
  • Revenue
  • APLS $775,839,000.00
  • AIR $2,682,500,000.00
  • Revenue This Year
  • APLS $1.01
  • AIR $18.46
  • Revenue Next Year
  • APLS $22.14
  • AIR $5.10
  • P/E Ratio
  • APLS N/A
  • AIR N/A
  • Revenue Growth
  • APLS 48.04
  • AIR 21.07
  • 52 Week Low
  • APLS $16.10
  • AIR $46.51
  • 52 Week High
  • APLS $42.47
  • AIR $76.34
  • Technical
  • Relative Strength Index (RSI)
  • APLS 42.98
  • AIR 66.00
  • Support Level
  • APLS $18.26
  • AIR $66.68
  • Resistance Level
  • APLS $19.96
  • AIR $69.36
  • Average True Range (ATR)
  • APLS 0.84
  • AIR 1.61
  • MACD
  • APLS -0.08
  • AIR -0.07
  • Stochastic Oscillator
  • APLS 19.22
  • AIR 79.47

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

About AIR AAR Corp.

AAR Corp is engaged in providing products and services to aviation, government, and defense market. It operates in three segments namely Parts Supply, Repair & Engineering, and Integrated Solutions. The parts supply segment majorly consists of sales and leasing of USM and aftermarket distribution of new, OEM-supplied replacement parts. Repair & Engineering segment provides airframe maintenance, component repair, and landing gear overhaul services. Integrated Solutions segment majorly consists of its fleet management and operations of customer-owned aircraft, customized performance-based supply chain logistics programs in support of the U.S. Department of Defense and foreign governments, flight hour component inventory and repair programs for commercial airlines.

Share on Social Networks: